JP3000023B2 - 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用 - Google Patents

新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用

Info

Publication number
JP3000023B2
JP3000023B2 JP7103170A JP10317095A JP3000023B2 JP 3000023 B2 JP3000023 B2 JP 3000023B2 JP 7103170 A JP7103170 A JP 7103170A JP 10317095 A JP10317095 A JP 10317095A JP 3000023 B2 JP3000023 B2 JP 3000023B2
Authority
JP
Japan
Prior art keywords
compound
group
general formula
hydrogen atom
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP7103170A
Other languages
English (en)
Japanese (ja)
Other versions
JPH07278177A (ja
Inventor
コンスタンタン・アグーリダ
ヤニク・ベネデッティ
ジャンフランソワ・シャント
アレクシ・ドニ
オディル・ル・マルトレ
Original Assignee
ヘキスト・マリオン・ルセル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヘキスト・マリオン・ルセル filed Critical ヘキスト・マリオン・ルセル
Publication of JPH07278177A publication Critical patent/JPH07278177A/ja
Application granted granted Critical
Publication of JP3000023B2 publication Critical patent/JP3000023B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP7103170A 1994-04-08 1995-04-05 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用 Expired - Lifetime JP3000023B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR94-04154 1994-04-08

Publications (2)

Publication Number Publication Date
JPH07278177A JPH07278177A (ja) 1995-10-24
JP3000023B2 true JP3000023B2 (ja) 2000-01-17

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7103170A Expired - Lifetime JP3000023B2 (ja) 1994-04-08 1995-04-05 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用

Country Status (49)

Country Link
US (2) US5656607A (https=)
EP (1) EP0676409B1 (https=)
JP (1) JP3000023B2 (https=)
KR (1) KR100317148B1 (https=)
CN (1) CN1059445C (https=)
AP (1) AP587A (https=)
AT (1) ATE234853T1 (https=)
AU (1) AU684939B2 (https=)
BG (1) BG61916B1 (https=)
BR (1) BR9506147A (https=)
CA (1) CA2164638C (https=)
CO (1) CO4370097A1 (https=)
CZ (1) CZ296005B6 (https=)
DE (1) DE69529934T2 (https=)
DK (1) DK0676409T3 (https=)
DZ (1) DZ1869A1 (https=)
EE (1) EE04498B1 (https=)
ES (1) ES2189820T3 (https=)
FI (1) FI111264B (https=)
FR (1) FR2718450B1 (https=)
GB (1) GB2288174A (https=)
GE (1) GEP19991836B (https=)
HR (1) HRP950217B1 (https=)
HU (1) HU215396B (https=)
IL (1) IL112954A (https=)
IS (1) IS1865B (https=)
JO (1) JO1850B1 (https=)
LV (1) LV11182B (https=)
MA (1) MA23501A1 (https=)
MD (1) MD663G2 (https=)
MY (1) MY114672A (https=)
NO (1) NO308361B1 (https=)
NZ (1) NZ284498A (https=)
OA (1) OA10200A (https=)
PE (1) PE2896A1 (https=)
PL (1) PL180837B1 (https=)
PT (1) PT676409E (https=)
RO (1) RO115634B1 (https=)
RU (1) RU2141965C1 (https=)
SA (1) SA97170757A (https=)
SI (1) SI0676409T1 (https=)
SK (1) SK284079B6 (https=)
SV (1) SV1995000018A (https=)
TN (1) TNSN95026A1 (https=)
TW (1) TW316908B (https=)
UA (1) UA44705C2 (https=)
WO (1) WO1995027720A1 (https=)
YU (1) YU49221B (https=)
ZA (1) ZA952059B (https=)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69733422T2 (de) * 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-0-substituierte ketoliden mit antibakteriellen wirkung
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6140479A (en) * 1997-03-24 2000-10-31 Taisho Pharmaceuticals Co., Ltd. Erythromycin a derivatives
WO1998051696A1 (en) * 1997-05-09 1998-11-19 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
ES2243066T3 (es) * 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
DE69933897T2 (de) 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamat- und Carbazatketolid-Antibiotika
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
CA2370743A1 (en) 1999-04-16 2000-10-26 Dennis Hlasta Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
CA2451391A1 (en) 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
US7332304B2 (en) 2002-07-01 2008-02-19 Arkion Life Sciences Llc Process and materials for production of glucosamine and N-acetylglucosamine
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
CA2523134A1 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) * 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692579A1 (fr) 1992-06-19 1993-12-24 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692579A1 (fr) 1992-06-19 1993-12-24 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
PL180837B1 (pl) 2001-04-30
FR2718450A1 (fr) 1995-10-13
EE04498B1 (et) 2005-06-15
MD663F1 (ro) 1997-01-31
SK154695A3 (en) 1996-10-02
RO115634B1 (ro) 2000-04-28
NO308361B1 (no) 2000-09-04
SI0676409T1 (en) 2003-06-30
MD663G2 (ro) 1997-07-31
YU21695A (sh) 1997-12-05
AP9500743A0 (en) 1995-07-31
UA44705C2 (uk) 2002-03-15
GB2288174A (en) 1995-10-11
JPH07278177A (ja) 1995-10-24
YU49221B (sh) 2004-11-25
IS1865B (is) 2003-05-02
SA97170757A (ar) 2005-12-03
IL112954A0 (en) 1995-06-29
GB9506856D0 (en) 1995-05-24
HRP950217B1 (en) 2004-06-30
NO954942L (no) 1996-02-07
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
EP0676409A1 (fr) 1995-10-11
KR100317148B1 (ko) 2002-06-22
MY114672A (en) 2002-12-31
LV11182A (lv) 1996-04-20
CO4370097A1 (es) 1996-10-07
FI955913A0 (fi) 1995-12-08
IL112954A (en) 2000-07-16
TW316908B (https=) 1997-10-01
BG100150A (bg) 1996-06-28
FR2718450B1 (fr) 1997-01-10
CA2164638A1 (fr) 1995-10-19
IS4309A (is) 1995-11-17
CZ296005B6 (cs) 2005-12-14
AU684939B2 (en) 1998-01-08
PE2896A1 (es) 1996-02-12
US5760233A (en) 1998-06-02
NZ284498A (en) 1997-07-27
CN1059445C (zh) 2000-12-13
WO1995027720A1 (fr) 1995-10-19
ZA952059B (en) 1996-03-13
NO954942D0 (no) 1995-12-06
PL311871A1 (en) 1996-03-18
EE9500080A (et) 1996-12-16
DZ1869A1 (fr) 2002-02-17
GEP19991836B (en) 1999-11-05
FI955913A7 (fi) 1995-12-08
HU9503505D0 (en) 1996-02-28
RU2141965C1 (ru) 1999-11-27
AU2310795A (en) 1995-10-30
CZ322395A3 (en) 1996-08-14
DE69529934T2 (de) 2003-09-04
US5656607A (en) 1997-08-12
BR9506147A (pt) 1996-04-16
LV11182B (en) 1997-04-20
MA23501A1 (fr) 1995-12-31
CN1126997A (zh) 1996-07-17
ES2189820T3 (es) 2003-07-16
TNSN95026A1 (fr) 1996-02-06
PT676409E (pt) 2003-08-29
OA10200A (fr) 1996-12-18
HU215396B (hu) 1998-12-28
DK0676409T3 (da) 2003-06-23
HUT73772A (en) 1996-09-30
SV1995000018A (es) 1997-10-24
AP587A (en) 1997-04-29
HRP950217A2 (en) 1997-08-31
FI111264B (fi) 2003-06-30
SK284079B6 (sk) 2004-09-08
DE69529934D1 (de) 2003-04-24
CA2164638C (fr) 2003-12-30
BG61916B1 (bg) 1998-09-30
ATE234853T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
JP3000023B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用
JP4750755B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用
JP3334980B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
JP4102440B2 (ja) 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用
JP4083824B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及び薬剤としての使用
JP4698783B2 (ja) エリスロマイシンの新誘導体、それらの製造方法及びそれらの薬剤としての使用
US6313101B1 (en) Derivatives of erythromycin, their preparation process and their use as medicaments
JP2000159790A (ja) 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用
JP4267700B2 (ja) エリスロマイシンの新規な誘導体、それらの製造法及びそれらの薬剤としての使用
JP2001506620A (ja) 新規なエリスロマイシン誘導体、それらの製造方法及びそれらの医薬としての利用
JP2001507011A (ja) 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
JP2003534231A (ja) 新規の６−デオキシエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19990525

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071112

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081112

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091112

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091112

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101112

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111112

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111112

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121112

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121112

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131112

Year of fee payment: 14

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term